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BACKGROUND: Bromelain is a sulfhydryl proteolytic enzyme that can hydrolyze protein, protease or peptide. Bromelain can be found in 
pineapple stem, fruit and core. Bromelain is composed of 212 
amino acid residues with cysteine-25 forming a polypeptide 
chain that can hydrolyze peptide bonds by H2O. In medicine, 
bromelain has been developed as antibiotic, cancer drug, 
anti-inflammatory agent and immunomodulator. In dentistry, 
bromelain has potential to reduce plaque formation on the 
teeth and to irigate root canal. 
METHODS: Pineapple core was dried for 3 days to get 
simplicia. Then simplicia was extracted with water solvent 
for 24 hours. After that, the macerated-pineapple core crude 
extract-derived bromelain (PCB) was separated by Sodium 
Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) followed by Coomassie Brilliant Blue (CBB) 
staining to ensure the presence of bromelain. In cytotoxic 
Abstract test, NIH-3T3 fibroblast cultures were treated with extracts in various concentrations to for 24 or 48 hours. Number of 
fibroblasts was calculated using 3-(4,5-dimethylthiazol-2-
yl)-2,5-Diphenyltetrazolium bromide (MTT) assay.
RESULTS: Pineapple core extraction using maceration 
method produced relative high yield (concentration: 1.5424 
g/mL) of bromelain, which was confirmed by CBB staining 
results with the molecular weight of 33 kDa. Based on 
cytotoxic test results of PCB on NIH-3T3 fibroblasts, 
24-hours-incubation LD50 was 95.7 g/L, while 48-hours-
incubation LD50 was 51.1 g/L.
CONCLUSION: PCB  has low cytotoxic effect in NIH-
3T3 fibroblasts.
KEYWORDS: bromelain, pineapple, extract, cytotoxic, 
MTT
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Introduction
Bromelain can be found in various parts of pineapple, 
including stem, leaf, crown, peel, fruit and core.(1) 
However, the core yielded highest bromelain activity 
recovery of 106% and 5.2 purification fold.(1) Beneficial 
effects of bromelain are related to its multiple constituents.
(2) Although primarily comprised of sulfhydryl-containing 
proteolytic enzymes, bromelain also contains escharase 
(2), peroxidase, acid phosphatase, glucosidases, cellulases, 
several protease inhibitors, glycoproteins, carbohydrates, 
and organically bound calcium.(3) Bromelain is made up 
of 212 amino acids and the molecular weight is 33 kDa.
(4) Bromeline is also composed of several distinct cysteine 
proteolytic fractions ranging in size from 15 to 27 kDa.(5)
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 Bromelain was widely reported to have various active 
molecular properties. It can activate various innate immune 
cells including macrophages, dendritic cells, natural killer 
cells and CD4+ T cells.(6-9) It can also induce apoptosis 
in skin tumors, breast cancer cells and gastrointestinal 
carcinoma cells (2,10) and inhibit L-1 cells tumor growth.
(11) In addition, bromelain can inhibit human cytochrome 
P450 2C9 activity.(12) In apoptosis induction, bromelain 
was reported to activate caspase cascades, cleavage of Poly 
Adenosine Diphosphate (ADP) Ribose Polymerase (PARP) 
and p53, overexpression of cytochrome C, attenuation of 
phosphorylated Akt and B Cell Lymphoma 2 (Bcl2), and 
removal of Mucin 1 (MUC1).(2) In contrary, bromelain 
was reported to have anti-apoptosis activity by increasing 
phosphorylation of Akt and Forkhead Homeobox type O 
(FOXO) 3A.(5) For anti-tumor and anti-inflammatory, 
Extracellular Signal-regulated Kinase 2 (ERK-2) Mitogen-
activated Protein Kinases (MAPK) and p21ras was disrupted 
by of bromelain.(13)
 Bromelain are considered to have a range of 
beneficial properties as anti-inflammatory, analgesic 
actions, anti-oedematous, anti-thrombotic, anti-diarrheal, 
antibiotics, anti-tumor, skin debridement, digestive aid, 
musculoskeletal injuries, reduces the blood pressure level, 
prevents aggregation of blood platelets, activates plasmin, 
supports the oxidative burst and fibrinolytic effects.(14-17) 
In humans, bromelain has been well documented to increase 
blood and urine levels of antibiotics and results in higher 
blood and tissue levels of tetracycline and amoxicillin 
when they are administered concurrently with bromelain.
(18) Bromelain has been successfully used as a digestive 
enzyme because of its wide pH range, bromelain has activity 
in the stomach as well as the small intestine.(19) In skin 
debridement, the use of topical bromelain for frostbite eschar 
removal was investigated, after two topical applications of 
Methods
bromelain, frostbite injuries remained un-affected.(20) In 
dentistry, bromelain exerts an anti-bacterial effect against 
potent periodontal pathogens, including Streptococcus 
mutans, Enterococcus faecalis, Aggregatibacter 
actinomycetemcomitans and Porphyromonas gingivalis.
(21) Since bromelain has many useful properties, we would 
like to know the safety of bromelain usage.  For this purpose, 
we currently performed pineapple core crude extract and 
cytotoxic test on NIH3T3 fibroblast.
Extraction of Bromelain from Pineapple Core 
Pineapples were collected from Bogor, Indonesia. 
Pineapples were peeled and its cores were collected. 
Pineapple cores were dried at 40°C for 3 days, weighed and 
milled. Extraction was performed using maceration method 
with water solvent in ratio of 1:10 for 24 hours at 4°C. 
The solvent was added 3 times in 24 hours, then filtered 
and evaporated with a rotary evaporator (Buchi Rotavapor 
R-124, Buchi, Flawil, Switzerland) at 40°C. Maceration 
results were stored in a refrigerator at 4°C.
Sodium Dodecyl Sulphate-Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) and Coomassie Brilliant 
Blue (CBB) Staining
Macerated-pineapple core crude extract was mixed with 
loading buffer in a ratio of 4:1 and boiled for 1 minute. Ten 
μl of boiled mixtures were then separated by SDS-PAGE 
followed by CBB staining for 30 minutes, to ensure the 
presence of bromelain.
NIH-3T3 Fibroblast Culture 
NIH-3T3 fibroblasts were cultured using Dulbecco’s 
Modified Eagle Medium containing 10% fetal bovine serum 
(FBS), penicillin, streptomycin, and amphotericin B in a 
humidified, 37°C, 5% CO2 incubator. Upon reaching 80% 
confluency, fibroblasts were subcultured and propagated.
Cytotoxic Test
Cytotoxic test was performed using 3-(4,5-dimethylthiazol-
2-yl)-2,5-Diphenyltetrazolium bromide (MTT) assay 
(Sigma) as described previously.(22,23) The MTT assay 
provides a quantitative measurement of viable fibroblasts by 
determining the amount of formazan crystals produced by 
metabolically active fibroblasts. Briefly, 1x104 fibroblasts 
were seeded into each well of 96-well plates in medium 
containing active agent, 1:1,000 diluted hydrogen peroxide 
or medium merely. Fibroblasts were incubated for 24 
Figure 1. CBB Staining of 
PCB. Macerated-pineapple 
core crude extract was 
separated with SDS-PAGE 
followed by CBB staining. 
SDS-PAGE and CBB 
staining were carried out at 
described in the Methods. 
A: size marker; B: PCB.
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Figure 2. NIH-3T3 fibroblasts expression after 
treatment of PCB. NIH-3T3 fibroblasts were 
seeded on glass slides in 6-cm culture dish. NIH-
3T3 fibroblasts were treated with 0 (A), 3.125 
(B), 6.25 (C), 12.5 (D), 25 (E) and 50% (F) PCB 
in DMEM containing 2% FBS for 48 hours. 
Fibroblasts were documented with an inverted light 
microscope. G: Fibroblasts were incorporated with 
MTT, formazan crystals were formed in fibroblasts. 
White bar: 50 μm.
or 48 hours. Ten μl of 5 mg/ml MTT in phosphate buffer 
saline (PBS) was added to each well. The plate was then 
incubated for 4 hours, and then the medium was discarded 
and formazan crystals were dissolved in 100 μl of 0.1N HCl. 
The absorbance of fibroblasts was measured at 570 nm by a 
microplate reader. Untreated fibroblasts were counted with 
a hemacytometer and used for interpolating the absorbance.
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Discussion
Figure 3. Effect of PCB on viability of NIH-3T3 fibroblasts for 
24 hours. Ten thousand NIH-3T3 fibroblasts were seeded into each 
well of 96-well plates. NIH-3T3 fibroblasts were treated with 0, 
3.125, 6.25, 12.5, 25 and 50% PCB in DMEM containing 2% FBS 
for 24 hours. Fibroblast viabilities were measured with MTT assay 
as described in Methods. A: Obtained absorbances were correlated 
with fibroblast density (1.0 fibroblast density equaled to 11,094 
fibroblasts). B: Interpolated number of viable NIH-3T3 fibroblasts 
after treated with PCB in various concentrations for 24 hours.
and x=percentage of medium. Since LD50=100-x, we found 
that 48-hours LD50 of PCB was 33.15%. This equaled to 
33.15% x 1.5424 g/mL x 1/10 = 0.0511 g/mL or 51.1 g/L.
We successfully produce high yield PCB with confirmed 
molecular weight. When PCB was added to NIH-3T3 
fibroblast cultures for 24 hours, number of NIH-3T3 
fibroblast was decreased slightly upon increasing PCB 
concentrations. Meanwhile additional decrease in number 
of NIH-3T3 fibroblast was obtained when the NIH-3T3 
fibroblast culture was treated for 48 hours. After calculation, 
we found that 24-hours-incubation LD50 of PCB was 95.7 
g/L and 48-hours-incubation LD50 of PCB was 51.1 g/L.
 Our results is in accordance with the studies reported 
for bromelain, which was considered to have very low 
toxicity.(24) It has been reported that LD50 was greater 
than 10 g/kg.(24) Moreover, in vivo toxic test on dogs, with 
increasing levels of bromelain up to 750 mg/kg administered 
daily, showed no toxic effects after six months.(24) Dosages 
of 1.5 g/kg/day administrated to rats showed no carcinogenic 
Macerated-Pineapple Core Crude Extract-derived 
Bromelain (PCB)
One hundred pineapples weighed 30 kg, were collected. 
After skin peeling and fruit removal, 7 kg of core were 
obtained. After drying, 700 g of simplicia was obtained. 
After maceration with water solvent and evaporation, 131.1 
g of crude extract with total volume of 85 mL (concentration: 
1.5424 g/mL), was obtained. The extract was then diluted 
1:10 for further purposes. Later on, macerated-pineapple 
core crude extract was examined for its content. We found 
that 33 kDa of bromelain in relative high yield contained in 
the extract, which was indicated by SDS-PAGE followed 
by CBB staining (Figure 1). Several possible cysteine 
proteolytic fractions of bromelain near to 19.2 kDa were 
observed as well. 
Effect of PCB on NIH-3T3 Fibroblasts
Our results showed that by addition of PCB in NIH-3T3 
fibroblast culture, number of NIH-3T3 fibroblasts were 
less when treated with higher concentration of bromelain 
(Figure 2). Highest fibroblast number was observed in 0% 
PCB, followed by 3.125% PCB, 6.25% PCB, 12.5% PCB, 
25% PCB and 50% PCB respectively. By counting the 
fibroblast number with MTT assay for 24 hours, we found 
that the number for the group treated with 0% PCB was 
11,088, while 3.125% PCB was 10,562; 6.25% PCB was 
9,953; 12.5% PCB was 9,621; 25% PCB was 7,711; 50% 
PCB was 6,992 (Figure 3A&B). Meanwhile, for fibroblast 
number with MTT assay for 48 hours, we found that the 
number for the group treated with 0% PCB was 13,087, 
while 3.125% PCB was 10,179; 6.25% PCB was 9,396; 
12.5% PCB was 8,650; 25% PCB was 6,600; 50% was 
5,928 (Figure 4A&B).
LD50 of PCB on NIH-3T3 Fibroblasts
Based on data from Figure 3, LD50 in 24 hours was calculated. 
Percentage of PCB was converted to percentage of medium. 
Then graph of percentage of medium against number of 
fibroblast was made. A median line of y=82.248x+2,425.5 
was obtained, y=number of fibroblast and x=percentage of 
medium. Therefore LD50=100-x. We found that 24-hours 
LD50 of PCB was 62.05%. This equaled to 62.05% x 
1.5424 g/mL x 1/10 = 0.0957 g/mL or 95.7 g/L. Meanwhile 
LD50 in 48 hours was calculated based on data Figure 4. 
Similar calculation method was performed. A median line 
of y=126.25x-1,471.6 was obtained, y=number of fibroblast 
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or teratogenic effects.(24) In human clinical test, side effects 
are generally not observed, however caution is advised if 
administering bromelain to individuals with hypertension 
since one report indicated individuals with pre-existing 
hypertension might experience tachycardia following 
high doses of bromelain.(25) Other experiments have 
previously shown that bromelain at high concentrations 
does not adversely affect cell viability, similarly, bromelain 
concentration of 50 mg/ml had no effect on the viability 
of chondrocytes.(26) Other experiments have previously 
shown that bromelain proteolytically removes certain 
cell surface molecules by cleavage of the peptide bond.
(13,27,28)
 PCB has low cytotoxic effect in NIH-3T3 fibroblasts, 
meanwhile there are many potential therapeutic benefits of 
bromelain, For example, bromelain exerts an anti-bacterial 
effect against potent periodontal pathogens, including 
Streptococcus mutans and Porphyromonas gingivalis.(21) 
Therefore, further studies in bacteria elimination should 
be pursued, whereas PCB could be useful to disrupt dental 
plaque formation disturbance and to irrigate root canal.
Figure 4. Effect of PCB on viability of NIH-3T3 fibroblasts for 
48 hours. Ten thousand NIH-3T3 fibroblasts were seeded into each 
well of 96-well plates. NIH-3T3 fibroblasts were treated with 0, 
3.125, 6.25, 12.5, 25 and 50% PCB in DMEM containing 2% FBS 
for 48 hours. Fibroblast viabilities were measured with MTT assay 
as described in Methods. A: Obtained absorbances were correlated 
with fibroblast density (1.0 fibroblast density equaled to 13,938 
fibroblasts). B: Interpolated number of viable NIH-3T3 fibroblasts 
after treated with PCB in various concentrations for 48 hours.
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